SrasV1, PubMed, Curation, bibRecord, 002940

Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus.

Identifieur interne : 002940 ( PubMed/Curation ); précédent : 002939; suivant : 002941

Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus.

Auteurs : Sara Akerström [Suède] ; Mehrdad Mousavi-Jazi ; Jonas Klingström ; Mikael Leijon ; Ake Lundkvist ; Ali Mirazimi

Source :

Journal of virology [ 0022-538X ] ; 2005.

RBID : pubmed:15650225

Descripteurs français

KwdFr :
- Animaux, Cellules Vero, Humains, Monoxyde d'azote (métabolisme), Monoxyde d'azote (pharmacologie), N-Acétyl-S-nitroso-pénicillamine (pharmacologie), Nitric oxide synthase (métabolisme), Nitric oxide synthase type II, Réplication virale (), Virus du SRAS (), Virus du SRAS (physiologie).
MESH :
- métabolisme : Monoxyde d'azote, Nitric oxide synthase.
- pharmacologie : Monoxyde d'azote, N-Acétyl-S-nitroso-pénicillamine.
- physiologie : Virus du SRAS.
- Animaux, Cellules Vero, Humains, Nitric oxide synthase type II, Réplication virale, Virus du SRAS.

English descriptors

KwdEn :
- Animals, Chlorocebus aethiops, Humans, Nitric Oxide (metabolism), Nitric Oxide (pharmacology), Nitric Oxide Synthase (metabolism), Nitric Oxide Synthase Type II, S-Nitroso-N-Acetylpenicillamine (pharmacology), SARS Virus (drug effects), SARS Virus (physiology), Vero Cells, Virus Replication (drug effects).
MESH :
- chemical , metabolism : Nitric Oxide, Nitric Oxide Synthase.
- chemical , pharmacology : Nitric Oxide, S-Nitroso-N-Acetylpenicillamine.
- drug effects : SARS Virus, Virus Replication.
- physiology : SARS Virus.
- Animals, Chlorocebus aethiops, Humans, Nitric Oxide Synthase Type II, Vero Cells.

Abstract

Nitric oxide (NO) is an important signaling molecule between cells which has been shown to have an inhibitory effect on some virus infections. The purpose of this study was to examine whether NO inhibits the replication cycle of the severe acute respiratory syndrome coronavirus (SARS CoV) in vitro. We found that an organic NO donor, S-nitroso-N-acetylpenicillamine, significantly inhibited the replication cycle of SARS CoV in a concentration-dependent manner. We also show here that NO inhibits viral protein and RNA synthesis. Furthermore, we demonstrate that NO generated by inducible nitric oxide synthase, an enzyme that produces NO, inhibits the SARS CoV replication cycle.

DOI: 10.1128/JVI.79.3.1966-1969.2005
PubMed: 15650225

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002940

Links to Exploration step

pubmed:15650225

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus.</title>
<author><name sortKey="Akerstrom, Sara" sort="Akerstrom, Sara" uniqKey="Akerstrom S" first="Sara" last="Akerström">Sara Akerström</name>
<affiliation wicri:level="1"><nlm:affiliation>Center for Microbiological Preparedness, Swedish Institute for Infectious Disease Control, 171 82 Solna, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Center for Microbiological Preparedness, Swedish Institute for Infectious Disease Control, 171 82 Solna</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mousavi Jazi, Mehrdad" sort="Mousavi Jazi, Mehrdad" uniqKey="Mousavi Jazi M" first="Mehrdad" last="Mousavi-Jazi">Mehrdad Mousavi-Jazi</name>
</author>
<author><name sortKey="Klingstrom, Jonas" sort="Klingstrom, Jonas" uniqKey="Klingstrom J" first="Jonas" last="Klingström">Jonas Klingström</name>
</author>
<author><name sortKey="Leijon, Mikael" sort="Leijon, Mikael" uniqKey="Leijon M" first="Mikael" last="Leijon">Mikael Leijon</name>
</author>
<author><name sortKey="Lundkvist, Ake" sort="Lundkvist, Ake" uniqKey="Lundkvist A" first="Ake" last="Lundkvist">Ake Lundkvist</name>
</author>
<author><name sortKey="Mirazimi, Ali" sort="Mirazimi, Ali" uniqKey="Mirazimi A" first="Ali" last="Mirazimi">Ali Mirazimi</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:15650225</idno>
<idno type="pmid">15650225</idno>
<idno type="doi">10.1128/JVI.79.3.1966-1969.2005</idno>
<idno type="wicri:Area/PubMed/Corpus">002940</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002940</idno>
<idno type="wicri:Area/PubMed/Curation">002940</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002940</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus.</title>
<author><name sortKey="Akerstrom, Sara" sort="Akerstrom, Sara" uniqKey="Akerstrom S" first="Sara" last="Akerström">Sara Akerström</name>
<affiliation wicri:level="1"><nlm:affiliation>Center for Microbiological Preparedness, Swedish Institute for Infectious Disease Control, 171 82 Solna, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Center for Microbiological Preparedness, Swedish Institute for Infectious Disease Control, 171 82 Solna</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mousavi Jazi, Mehrdad" sort="Mousavi Jazi, Mehrdad" uniqKey="Mousavi Jazi M" first="Mehrdad" last="Mousavi-Jazi">Mehrdad Mousavi-Jazi</name>
</author>
<author><name sortKey="Klingstrom, Jonas" sort="Klingstrom, Jonas" uniqKey="Klingstrom J" first="Jonas" last="Klingström">Jonas Klingström</name>
</author>
<author><name sortKey="Leijon, Mikael" sort="Leijon, Mikael" uniqKey="Leijon M" first="Mikael" last="Leijon">Mikael Leijon</name>
</author>
<author><name sortKey="Lundkvist, Ake" sort="Lundkvist, Ake" uniqKey="Lundkvist A" first="Ake" last="Lundkvist">Ake Lundkvist</name>
</author>
<author><name sortKey="Mirazimi, Ali" sort="Mirazimi, Ali" uniqKey="Mirazimi A" first="Ali" last="Mirazimi">Ali Mirazimi</name>
</author>
</analytic>
<series><title level="j">Journal of virology</title>
<idno type="ISSN">0022-538X</idno>
<imprint><date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Chlorocebus aethiops</term>
<term>Humans</term>
<term>Nitric Oxide (metabolism)</term>
<term>Nitric Oxide (pharmacology)</term>
<term>Nitric Oxide Synthase (metabolism)</term>
<term>Nitric Oxide Synthase Type II</term>
<term>S-Nitroso-N-Acetylpenicillamine (pharmacology)</term>
<term>SARS Virus (drug effects)</term>
<term>SARS Virus (physiology)</term>
<term>Vero Cells</term>
<term>Virus Replication (drug effects)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Cellules Vero</term>
<term>Humains</term>
<term>Monoxyde d'azote (métabolisme)</term>
<term>Monoxyde d'azote (pharmacologie)</term>
<term>N-Acétyl-S-nitroso-pénicillamine (pharmacologie)</term>
<term>Nitric oxide synthase (métabolisme)</term>
<term>Nitric oxide synthase type II</term>
<term>Réplication virale ()</term>
<term>Virus du SRAS ()</term>
<term>Virus du SRAS (physiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Nitric Oxide</term>
<term>Nitric Oxide Synthase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Nitric Oxide</term>
<term>S-Nitroso-N-Acetylpenicillamine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>SARS Virus</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Monoxyde d'azote</term>
<term>Nitric oxide synthase</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Monoxyde d'azote</term>
<term>N-Acétyl-S-nitroso-pénicillamine</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Chlorocebus aethiops</term>
<term>Humans</term>
<term>Nitric Oxide Synthase Type II</term>
<term>Vero Cells</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Cellules Vero</term>
<term>Humains</term>
<term>Nitric oxide synthase type II</term>
<term>Réplication virale</term>
<term>Virus du SRAS</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Nitric oxide (NO) is an important signaling molecule between cells which has been shown to have an inhibitory effect on some virus infections. The purpose of this study was to examine whether NO inhibits the replication cycle of the severe acute respiratory syndrome coronavirus (SARS CoV) in vitro. We found that an organic NO donor, S-nitroso-N-acetylpenicillamine, significantly inhibited the replication cycle of SARS CoV in a concentration-dependent manner. We also show here that NO inhibits viral protein and RNA synthesis. Furthermore, we demonstrate that NO generated by inducible nitric oxide synthase, an enzyme that produces NO, inhibits the SARS CoV replication cycle.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15650225</PMID>
<DateCompleted><Year>2005</Year>
<Month>02</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-538X</ISSN>
<JournalIssue CitedMedium="Print"><Volume>79</Volume>
<Issue>3</Issue>
<PubDate><Year>2005</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Journal of virology</Title>
<ISOAbbreviation>J. Virol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus.</ArticleTitle>
<Pagination><MedlinePgn>1966-9</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Nitric oxide (NO) is an important signaling molecule between cells which has been shown to have an inhibitory effect on some virus infections. The purpose of this study was to examine whether NO inhibits the replication cycle of the severe acute respiratory syndrome coronavirus (SARS CoV) in vitro. We found that an organic NO donor, S-nitroso-N-acetylpenicillamine, significantly inhibited the replication cycle of SARS CoV in a concentration-dependent manner. We also show here that NO inhibits viral protein and RNA synthesis. Furthermore, we demonstrate that NO generated by inducible nitric oxide synthase, an enzyme that produces NO, inhibits the SARS CoV replication cycle.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Akerström</LastName>
<ForeName>Sara</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Center for Microbiological Preparedness, Swedish Institute for Infectious Disease Control, 171 82 Solna, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mousavi-Jazi</LastName>
<ForeName>Mehrdad</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Klingström</LastName>
<ForeName>Jonas</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Leijon</LastName>
<ForeName>Mikael</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lundkvist</LastName>
<ForeName>Ake</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Mirazimi</LastName>
<ForeName>Ali</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Virol</MedlineTA>
<NlmUniqueID>0113724</NlmUniqueID>
<ISSNLinking>0022-538X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>31C4KY9ESH</RegistryNumber>
<NameOfSubstance UI="D009569">Nitric Oxide</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>79032-48-7</RegistryNumber>
<NameOfSubstance UI="D026423">S-Nitroso-N-Acetylpenicillamine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 1.14.13.39</RegistryNumber>
<NameOfSubstance UI="C496319">NOS2 protein, human</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 1.14.13.39</RegistryNumber>
<NameOfSubstance UI="D019001">Nitric Oxide Synthase</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 1.14.13.39</RegistryNumber>
<NameOfSubstance UI="D052247">Nitric Oxide Synthase Type II</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009569" MajorTopicYN="N">Nitric Oxide</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019001" MajorTopicYN="N">Nitric Oxide Synthase</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D052247" MajorTopicYN="N">Nitric Oxide Synthase Type II</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D026423" MajorTopicYN="N">S-Nitroso-N-Acetylpenicillamine</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year>
<Month>1</Month>
<Day>15</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2005</Year>
<Month>2</Month>
<Day>11</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2005</Year>
<Month>1</Month>
<Day>15</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15650225</ArticleId>
<ArticleId IdType="pii">79/3/1966</ArticleId>
<ArticleId IdType="doi">10.1128/JVI.79.3.1966-1969.2005</ArticleId>
<ArticleId IdType="pmc">PMC544093</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2448-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8637894</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1995 Nov;69(11):7001-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7474119</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1997 Mar;71(3):2202-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9032354</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 1997 May 5;185(9):1533-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9151890</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1997 Jul;71(7):5227-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9188590</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1998 Sep;72(9):7084-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9696801</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chest. 1998 Aug;114(2):452-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9726729</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 1998 Oct 19;188(8):1541-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9782132</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Mol Life Sci. 1999 Jul;55(8-9):1015-28</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10484661</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1999 Oct;73(10):8880-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10482647</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunology. 1999 Nov;98(3):363-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10583595</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2000 Sep;74(17):8048-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10933714</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2000 Oct;74(19):8904-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10982333</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Respir Crit Care Med. 2001 Feb;163(2):532-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11179135</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Biochem Biophys. 2001 Jul 1;391(1):1-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11414678</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int Immunopharmacol. 2001 Aug;1(8):1397-406</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11515807</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Kidney Int. 2002 Feb;61(2):444-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11849384</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2003 May 30;300(5624):1394-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730500</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2003 May 30;300(5624):1399-404</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730501</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2003 May 24;361(9371):1761-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12781533</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2003 Jul 26;362(9380):293-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12892961</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2003 Oct;41(10):4521-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14532176</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Crit Care Med. 2003 Nov;31(11):2684-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14605542</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Virol. 2004 Jan;72(1):83-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14635015</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2004 Jan;42(1):347-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14715775</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Exp Immunol. 2004 Apr;136(1):95-103</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15030519</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Apr;78(8):4323-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15047845</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Anal Biochem. 1982 Oct;126(1):131-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7181105</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 1992 Apr 10;256(5054):225-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1373522</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3491-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7682706</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Immunol. 1994 Apr;24(4):980-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8149966</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10089-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7524082</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7809-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7544004</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 1996 May 1;183(5):2293-302</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8642338</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002940 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002940 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:15650225
   |texte=   Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:15650225" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus.

Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki